Medical device recalls Moderate risk

SIGHT DIAGNOSTICS LTD recalls Sight OLO, Automated Hematology Analyzer, Catalog No. OLO-U1

Recall date
June 14, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1469-2022
FDA classification
Class II
Brand / firm
SIGHT DIAGNOSTICS LTD
Sold / distributed
Worldwide distribution - US Nationwide distribution in the states of Alabama, Arizona, California, Florida, Idaho, Illinois, Kansas, Kentucky, Massachusetts, Michigan, Minnesota, Mississippi, New Jersey, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin and the c…

Why it was recalled

The default reference ranges for MCH, MCHC, and RDW for age group "Child 2-11y" are mixed up and incorrectly displayed on OLO devices running software version 2.63, 2.63.1, and 2.63.1.1. Due to the issue, results may incorrectly appear to be within or outside the reference range.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Sight OLO, Automated Hematology Analyzer, Catalog No. OLO-U1

Get recall alerts

Free email alert whenever SIGHT DIAGNOSTICS LTD has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SIGHT DIAGNOSTICS LTD